Ibalgin

Ibuprofen, the active ingredient in Ibalgin, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain, fever and inflammation in adults and children when prescribed by a health‑care professional.

GNH USA supplies Ibalgin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibalgin (ibuprofen) is used to relieve symptoms in several common inflammatory pathways.

Pain: reduces mild to moderate pain such as headache, dental or musculoskeletal discomfort. Fever: lowers elevated body temperature associated with infections or inflammatory conditions. Inflammation: alleviates swelling and stiffness in conditions like arthritis or soft‑tissue injury.

Adverse reactions may occur with ibuprofen use and are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal discomfort such as nausea or dyspepsia. - Headache or dizziness. - Mild skin rash or itching. - Elevated blood pressure in susceptible individuals. - Transient increase in serum creatinine.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Severe allergic reactions including anaphylaxis. - Hepatotoxicity or elevated liver enzymes. - Renal impairment or acute kidney injury. - Cardiovascular events such as myocardial infarction or stroke. - Blood dyscrasias like thrombocytopenia.

Before using Ibalgin, consider the following safety measures.

Assess renal function: avoid use in patients with severe kidney disease. Monitor cardiovascular risk: use cautiously in individuals with heart disease. Check for gastrointestinal history: avoid in patients with active ulcers or bleeding. Avoid concurrent NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs. Pregnancy and lactation: consult a physician before use during pregnancy or while breastfeeding. Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can interact with several medication classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - High‑dose aspirin: heightened gastrointestinal toxicity. - Selective COX‑2 inhibitors: additive renal and cardiovascular risk. - Certain antihypertensives (e.g., ACE inhibitors, diuretics): may reduce blood‑pressure control. - Lithium: ibuprofen can raise serum lithium levels.

Moderate Interactions (Monitor Closely): - Methotrexate: possible increase in toxicity. - Corticosteroids: enhanced risk of gastrointestinal ulceration. - SSRIs or SNRIs: modestly increased bleeding tendency. - Diuretics: potential for reduced renal perfusion. - Antidiabetic agents: may affect glycemic control.